Abstract

IntroductionThe different distribution of T cells among activation/differentiation stages in immune disorders may condition the outcome of mesenchymal stromal cell (MSC)-based therapies. Indeed, the effect of MSCs in the different functional compartments of T cells is not completely elucidated.MethodsWe investigated the effect of human bone marrow MSCs on naturally occurring peripheral blood functional compartments of CD4+ and CD8+ T cells: naive, central memory, effector memory, and effector compartments. For that, mononuclear cells (MNCs) stimulated with phorbol myristate acetate (PMA) plus ionomycin were cultured in the absence/presence of MSCs. The percentage of cells expressing tumor necrosis factor-alpha (TNF-α), interferon gamma (IFNγ), and interleukin-2 (IL-2), IL-17, IL-9, and IL-6 and the amount of cytokine produced were assessed by flow cytometry. mRNA levels of IL-4, IL-10, transforming growth factor-beta (TGF-β), and cytotoxic T-lymphocyte-associated protein 4 (CTLA4) in purified CD4+ and CD8+ T cells, and phenotypic and mRNA expression changes induced by PMA + ionomycin stimulation in MSCs, were also evaluated.ResultsMSCs induced the reduction of the percentage of CD4+ and CD8+ T cells producing TNF-α, IFNγ, and IL-2 in all functional compartments, except for naive IFNγ+CD4+ T cells. This inhibitory effect differentially affected CD4+ and CD8+ T cells as well as the T-cell functional compartments; remarkably, different cytokines showed distinct patterns of inhibition regarding both the percentage of producing cells and the amount of cytokine produced. Likewise, the percentages of IL-17+, IL-17+TNF-α+, and IL-9+ within CD4+ and CD8+ T cells and of IL-6+CD4+ T cells were decreased in MNC-MSC co-cultures. MSCs decreased IL-10 and increased IL-4 mRNA expression in stimulated CD4+ and CD8+ T cells, whereas TGF-β was reduced in CD8+ and augmented in CD4+ T cells, with no changes for CTLA4. Finally, PMA + ionomycin stimulation did not induce significant alterations on MSCs phenotype but did increase indoleamine-2,3-dioxygenase (IDO), inducible costimulatory ligand (ICOSL), IL-1β, IL-8, and TNF-α mRNA expression.ConclusionsOverall, our study showed that MSCs differentially regulate the functional compartments of CD4+ and CD8+ T cells, which may differentially impact their therapeutic effect in immune disorders. Furthermore, the influence of MSCs on IL-9 expression can open new possibilities for MSC-based therapy in allergic diseases.Electronic supplementary materialThe online version of this article (doi:10.1186/scrt537) contains supplementary material, which is available to authorized users.

Highlights

  • The different distribution of T cells among activation/differentiation stages in immune disorders may condition the outcome of mesenchymal stromal cell (MSC)-based therapies

  • To investigate the ability of MSCs to regulate cytokine protein expression in CD4+ and CD8+ T cells and how the influence of MSCs varies among the different T-cell functional compartments, non-stimulated or phorbol myristate acetate (PMA) + ionomycinstimulated mononuclear cell (MNC) were cultured in the absence or presence of MSCs

  • Co-culture of MSCs with PMA + ionomycin-stimulated MNCs decreased the percentage of both CD4+ and CD8+ T cells expressing tumor necrosis factor-alpha (TNF-α) (P

Read more

Summary

Introduction

The different distribution of T cells among activation/differentiation stages in immune disorders may condition the outcome of mesenchymal stromal cell (MSC)-based therapies. The suppressive effect of MSCs over T cells comprises inhibition of T-cell proliferation, activation, differentiation in effector cells, and effector function by altering their cytokine profile and impairing the cytolytic activity of cytotoxic T cells [1]. Human bone marrow (BM) MSCs impair dendritic cell maturation and decrease the expression of co-stimulatory molecules and interleukin-12 (IL-12) while increasing IL-10 expression and hampering T-cell activation [2,3,4,5,6]. The information available on the effect of MSCs over T cells at different stages of activation/differentiation is scarce, and the data concerning the influence of MSCs on the naive-effector T-cell differentiation process are contradictory. Some studies reported that MSCs promote Th17 differentiation and IL-17A production [1,20,21,22,23]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call